with such massive volumes the past few days (even unusual if it does get a SkyNews mention) could a deal have already been struck with a pharma to see the final trial to a successful conclusion and get this drug on market in 2011?
at least EMS has enough cash plus some to see it through to the end of the final trial.
AFG Venture Group has now had 6 months to work on a deal.
And the data from IIa trial was really good. Superior to IV Quinine!
or wishful thinking?
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.394M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| EMS (ASX) Chart |
Day chart unavailable